The article examines the objective, findings, and clinical context described in Top 10 evidence-based essentials in ObGyn.
Approach:
Cervical screening: ASCCP risk-based guidelines use current and prior HPV and cytology results to estimate precancer risk and guide management.
Hypertensive disorders of pregnancy: ACOG’s practice bulletin provides guidance on diagnosing and managing gestational hypertension and preeclampsia.
Fetal growth restriction: SMFM Consult Series #52 addresses diagnosis, ultrasound and umbilical artery Doppler assessment, fetal surveillance, and delivery timing.
Infertility evaluation: ASRM guidance covers evaluation timing, indications for earlier assessment, diagnostic testing, and concurrent evaluation of both partners when relevant.
Chronic hypertension trial: The trial compared targeting blood pressure below 140/90 mm Hg with reserving treatment for severe hypertension during pregnancy.
ARRIVE trial: The trial compared induction at 39 weeks with expectant management in low-risk nulliparous patients.
Women’s Health Initiative: Randomized trials evaluated menopausal hormone therapy and outcomes including symptoms, cardiovascular disease, cognition, and bone health.
Long-acting reversible contraception: ACOG guidance reviews candidate selection and clinical use of contraceptive implants and intrauterine devices.
Key Findings:
In the Chronic Hypertension and Pregnancy trial, targeting blood pressure below 140/90 mm Hg was associated with a lower incidence of the primary composite outcome than reserving treatment for severe hypertension; active treatment did not increase small-for-ge…
In ARRIVE, induction at 39 weeks was associated with a lower cesarean delivery rate than expectant management; the groups did not differ significantly in the composite adverse perinatal outcome.
Interpretation:
The framework brings together clinical guidance, trial findings, and risk-assessment tools relevant to multiple areas of ObGyn care.
Recent CDC advisories, testing updates, and immunization recommendations highlight developments in infectious diseases, immunization, and diagnostic testing relevant to physicians across multiple specialties.
Achievable goals, activity tracking, and social support are among the strategies JAMA researchers recommend for patients with chronic medical conditions.
